Article
Anti-Idiotypic mRNA Vaccine to Treat Autoimmune Disorders
21 Dec 2023
Abstract excerpt
The 80+ existing autoimmune disorders (ADs) affect billions with little prevention or treatment options, except for temporary symptomatic management, leading to enormous human suffering and a monumental financial burden. The autoantibodies formed in most ADs have been identified, allowing the development of novel anti-idiotypic antibodies to mute the autoantibodies using vaccines. Nucleoside vaccines have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
